Back
Speaker illustration

Doctor Mohammed Ammar

Harvard Medical School, Boston (United States of America)

Member of:

European Society of Cardiology

Presentations

Immunoglobulin G N-glycosylation as a novel biomarker for premature myocardial infarction: a case-control study

Event: ESC Congress 2025

Topic: Biomarkers

Session: Cardiovascular risk assessment: biomarkers (3)

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources